Loading insider details...
Beta
Latest Form 4 (Aug 14, 2026): Exercise/Conversion of 16,179 LGND shares, $854.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 14, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | Exercise/Conversion | 16,179 | $854.9K |
| Jul 6, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | Other (see footnotes) | 17 | $2.7K |
| May 28, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | Exercise/Conversion | 764 | $48.6K |
| Mar 28, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | Grant/Award | 4,933 | n/a |
| Mar 13, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | Exercise/Conversion | 2,405 | $222.8K |
| Mar 6, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | Exercise/Conversion | 1,607 | $94.0K |
| Feb 18, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | Grant/Award | 7,390 | n/a |
| Jan 7, 2026 | LIGAND PHARMACEUTICALS INC (LGND) | Other (see footnotes) | 8 | $765.41 |
| Dec 18, 2025 | LIGAND PHARMACEUTICALS INC (LGND) | Exercise/Conversion | 1,194 | $63.1K |
| Dec 16, 2025 | LIGAND PHARMACEUTICALS INC (LGND) | Sale | 1,804 | $339.7K |